Home LiteratureArticle Details
PMID: 14694094 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.

Journal of virology ·Vol. 78 ·No. 2 ·2004-01-00 ·Pages 630-41

Draenert R, Verrill CL, Tang Y, Allen TM, Wurcel AG, Boczanowski M, Lechner A, Kim AY, Suscovich T, Brown NV, Addo MM, Walker BD

Abstract

CD8 T-cell responses are thought to be crucial for control of viremia in human immunodeficiency virus (HIV) infection but ultimately fail to control viremia in most infected persons. Studies in acute infection have demonstrated strong CD8-mediated selection pressure and evolution of mutations conferring escape from recognition, but the ability of CD8 T-cell responses that persist in late-stage infection to recognize viruses present in vivo has not been determined. Therefore, we studied 24 subjects with advanced HIV disease (median viral load = 142,000 copies/ml; median CD4 count = 71/ micro l) and determined HIV-1-specific CD8 T-cell responses to all expressed viral proteins using overlapping peptides by gamma interferon Elispot assay. Chronic-stage virus was sequenced to evaluate autologous sequences within Gag epitopes, and functional avidity of detected responses was determined. In these subjects, the median number of epitopic regions targeted was 13 (range, 2 to 39) and the median cumulative magnitude of CD8 T-cell responses was 5,760 spot-forming cells/10(6) peripheral blood mononuclear cells (range, 185 to 24,700). On average six (range, one to 8) proteins were targeted. For 89% of evaluated CD8 T-cell responses, the autologous viral sequence was predicted to be well recognized by these responses and the majority of analyzed optimal epitopes were recognized with medium to high functional avidity by the contemporary CD8 T cells. Withdrawal of antigen by highly active antiretroviral therapy led to a significant decline both in breadth (P = 0.032) and magnitude (P = 0.0098) of these CD8 T-cell responses, providing further evidence that these responses had been driven by recognition of autologous virus. These results indicate that strong, broadly directed, and high-avidity gamma-interferon-positive CD8 T-cells directed at autologous virus persist in late disease stages, and the absence of mutations within viral epitopes indicates a lack of strong selection pressure mediated by these responses. These data imply functional impairment of CD8 T-cell responses in late-stage infection that may not be reflected by gamma interferon-based screening techniques.

MeSH Terms
Amino Acid Sequence CD8-Positive T-Lymphocytes/immunology Chronic Disease Disease Progression Epitopes, T-Lymphocyte/chemistry,immunology Gene Products, gag/chemistry,genetics,immunology HIV Infections/immunology,virology HIV-1/immunology Humans Interferon-gamma/biosynthesis Molecular Sequence Data Peptides/chemical synthesis,chemistry,immunology Viral Proteins/chemistry,genetics,immunology
Chemicals
Epitopes, T-Lymphocyte Gene Products, gag Peptides Viral Proteins Interferon-gamma
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Draenert R
Howard Hughes Medical Institute, Partners AIDS Research Center, Massachusetts General Hospital and Harvard Medical School Division of AIDS, Boston, Massachusetts 02129, USA.
Verrill C L
Tang Y
Allen T M
Wurcel A G
Boczanowski M
Lechner A
Kim A Y
Suscovich T
Brown N V
Addo M M
Walker B D
References (58)
58 references, click to expand
  1. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  2. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.
    J Exp Med. 2001 Jan 15;193(2):181-94 PMID: 11148222
  3. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
    J Virol. 1999 Jul;73(7):5509-19 PMID: 10364299
  4. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
    Curr Opin Immunol. 1999 Aug;11(4):451-9 PMID: 10448136
  5. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
    Nat Med. 1997 Feb;3(2):205-11 PMID: 9018240
  6. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    J Virol. 1999 Dec;73(12):10191-8 PMID: 10559335
  7. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.
    J Virol. 2000 Jun;74(11):5291-9 PMID: 10799606
  8. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    J Virol. 2000 Sep;74(18):8541-9 PMID: 10954555
  9. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
    Nature. 2000 Sep 21;407(6802):386-90 PMID: 11014195
  10. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Science. 2000 Oct 20;290(5491):486-92 PMID: 11039923
  11. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
    Blood. 2000 Nov 1;96(9):3094-101 PMID: 11049989
  12. Differences between T cell epitopes recognized after immunization and after infection.
    J Immunol. 2002 Oct 15;169(8):4511-21 PMID: 12370388
  13. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13747-52 PMID: 12370434
  14. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Nat Immunol. 2002 Nov;3(11):1061-8 PMID: 12368910
  15. Immunology taught by Darwin.
    Nat Immunol. 2002 Nov;3(11):987-9 PMID: 12407405
  16. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
    Nature. 2002 Nov 28;420(6914):434-9 PMID: 12459786
  17. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.
    Blood. 2003 Jan 1;101(1):226-35 PMID: 12393740
  18. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    J Virol. 2003 Feb;77(3):2081-92 PMID: 12525643
  19. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.
    Virology. 2001 Jan 5;279(1):136-45 PMID: 11145897
  20. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    J Immunol Methods. 2003 Apr 1;275(1-2):19-29 PMID: 12667667
  21. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.
    J Exp Med. 2001 Jan 15;193(2):169-80 PMID: 11148221
  22. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
    J Exp Med. 2001 Feb 5;193(3):375-86 PMID: 11157057
  23. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.
    J Immunol. 2001 Feb 1;166(3):1690-7 PMID: 11160212
  24. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Nature. 2001 Mar 1;410(6824):106-11 PMID: 11242051
  25. The role of T cell help for anti-viral CTL responses.
    J Theor Biol. 2001 Aug 21;211(4):419-32 PMID: 11476625
  26. Vpr is preferentially targeted by CTL during HIV-1 infection.
    J Immunol. 2001 Sep 1;167(5):2743-52 PMID: 11509618
  27. Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production.
    Immunol Lett. 2001 Nov 1;79(1-2):117-25 PMID: 11595298
  28. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
    J Infect Dis. 2001 Dec 1;184(11):1465-9 PMID: 11709791
  29. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    J Virol. 2001 Dec;75(24):11983-91 PMID: 11711588
  30. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.
    J Virol. 2002 Mar;76(5):2298-305 PMID: 11836408
  31. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.
    Nat Med. 2002 Apr;8(4):379-85 PMID: 11927944
  32. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
    Nat Med. 2002 May;8(5):493-9 PMID: 11984594
  33. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    J Virol. 2002 Jul;76(14):7187-202 PMID: 12072518
  34. Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection.
    AIDS. 2002 Oct 18;16(15):2001-11 PMID: 12370498
  35. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  36. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  37. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    J Exp Med. 1995 Apr 1;181(4):1365-72 PMID: 7699324
  38. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.
    Nat Med. 1996 Mar;2(3):338-42 PMID: 8612235
  39. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
    Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4102-7 PMID: 8633023
  40. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
    Science. 1996 May 24;272(5265):1167-70 PMID: 8638160
  41. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.
    J Exp Med. 2003 May 19;197(10):1365-75 PMID: 12743169
  42. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    J Virol. 2003 Jun;77(12):6867-78 PMID: 12768006
  43. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    J Virol. 2003 Jun;77(12):6889-98 PMID: 12768008
  44. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.
    J Virol. 2003 Jul;77(13):7330-40 PMID: 12805431
  45. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
    AIDS. 2003 Dec 5;17(18):2581-91 PMID: 14685052
  46. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Nature. 1987 Jul 23-29;328(6128):345-8 PMID: 3496541
  47. AIDS virus-specific cytotoxic T lymphocytes in lung disorders.
    Nature. 1987 Jul 23-29;328(6128):348-51 PMID: 3496542
  48. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity.
    Eur J Immunol. 1991 Oct;21(10):2637-40 PMID: 1717289
  49. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
    Nat Med. 1997 Feb;3(2):212-7 PMID: 9018241
  50. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5 PMID: 9050875
  51. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
    J Gen Virol. 1997 Aug;78 ( Pt 8):1913-8 PMID: 9266987
  52. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
    Nature. 1998 Jan 22;391(6665):397-401 PMID: 9450757
  53. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
    Science. 1998 Mar 27;279(5359):2103-6 PMID: 9516110
  54. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  55. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus.
    J Virol. 2003 Feb;77(3):2165-73 PMID: 12525651
  56. Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study.
    J Infect Dis. 2003 Mar 15;187(6):887-95 PMID: 12660934
  57. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
    J Virol. 2003 Apr;77(8):4911-27 PMID: 12663797
  58. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
    J Immunol. 1999 Mar 15;162(6):3727-34 PMID: 10092836
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-01-00
Pages
630-41
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC368768
Subset
IM
Grants
NIAID NIH HHS · R01 AI28568 · United States
PHS HHS · N01-A1-15442 · United States
NIAID NIH HHS · R01 AI054178 · United States
NIAID NIH HHS · R01 AI028568 · United States
NIAID NIH HHS · R56 AI054178 · United States
NIAID NIH HHS · AI054178-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com